Tests:Lithium, Serum: Difference between revisions
Tests:Lithium, Serum
No edit summary |
Updated method Alinity |
||
| (3 intermediate revisions by 3 users not shown) | |||
| Line 19: | Line 19: | ||
Priadel | Priadel | ||
|- | |- | ||
| | |Availability | ||
|Monday - Sunday, testing routinely available out of hours | |Monday - Sunday, testing routinely available out of hours | ||
|- | |- | ||
| Line 26: | Line 26: | ||
|- | |- | ||
|Stability – Add test | |Stability – Add test | ||
| | |5 days | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Specimen Requirements == | == Specimen Requirements == | ||
|- | |- | ||
|Specimen | |Patient Preparation | ||
|Sample should be taken as a trough, ideally 12 hours post dose | |||
|- | |||
|Specimen | |||
|Serum | |Serum | ||
|- | |- | ||
|Preferred | |Preferred | ||
| | |Plain Yellow top or <span style="background:#e30022"> Red-Top</span> tube | ||
|- | |- | ||
|Acceptable | |Acceptable | ||
| Line 41: | Line 44: | ||
|- | |- | ||
|Unacceptable | |Unacceptable | ||
|Li-Hep | |Li-Hep Green-top tubes | ||
|- | |- | ||
|Specimen Transportation | |Specimen Transportation | ||
| Line 47: | Line 50: | ||
|- | |- | ||
|Paediatric Requirements | |Paediatric Requirements | ||
|1 mL <span style="background:#e30022"> Red-Top</span> | |1 mL <span style="background:#e30022"> Red-Top</span> tube | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== Aliquot Requirements == | == Aliquot Requirements == | ||
|- | |- | ||
|Sample | |Sample | ||
|Serum | |Serum | ||
|- | |- | ||
|Preferred Volume | |Preferred Volume | ||
| | |0.5 mL | ||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
| Line 68: | Line 71: | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
|Therapeutic Range 0.4 - 1.2 mmol/L | |Therapeutic Range 0.4 - 1.2 mmol/L | ||
For prophylaxis, a concentration of 0.4 - 0.8 mmol/L may be optimal. | |||
A range of 0.8 - 1.2 mmol/L is suggested for acute mania. | |||
Toxicity is common above 1.2 mmol/L and may be severe. | |||
Lithium clearance is reduced with renal impairment. | |||
|- | |- | ||
|Test Method | |Test Method | ||
|Abbott Alinity | |Abbott Alinity c series analyser using Abbott reagents. | ||
Colorimetric assay. | |||
|- | |- | ||
|Advanced Notice | |Advanced Notice | ||
| | | | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
| Line 84: | Line 89: | ||
| colspan="2" |Please supply last dose time and date if available | | colspan="2" |Please supply last dose time and date if available | ||
|} | |} | ||
{{DocMeta | |||
| owner = Crossley1 | |||
| review_ping = | |||
}} | |||